Lobular capillary hemangioma of the nasal septum – A case report

Kamath, Panduranga M; Shenoy, Srinivas Vinayak; Kini, Jyoti R.; Mukundan, Aswin

doi:10.1016/j.ejenta.2014.07.004

Cited by 7 publications

(11 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patrice et al reported a series of 178 patients with LCH. Seventy-four per cent of their cases had no history of trauma [10].In our patients, none of these potential etiological factors were present, it is consistent with another report [11].It should be noted that contrast enhanced MRI is the preferred method for imaging, although CT scan can also be considered if MRI is not available. Furthermore CT scan may demonstrate bony expansion or erosion [12].…”

Section: Discussionsupporting

confidence: 90%

Lobular Capillary Hemangioma of the Ethmoid Sinus: A Report of Two Cases

Binesh

Khajehzadeh

Kargar

et al. 2015

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

Soft-tissue tumors are rare in the paranasal region. Lobular capillary hemangioma (LCH) is a distinctive vascular lesion most commonly seen on the skin and oral mucosa in the fourth and fifth decades of life. Forasmuch as the nasal cavity and paranasal sinuses are rare locations for LCH, it is not well known by many ENT surgeons. Here we present two cases of LCH of the ethmoid sinus. These cases are being reported owing to their scarcity as per the literature published global.

show abstract

Section: Discussionsupporting

confidence: 90%

Lobular Capillary Hemangioma of the Ethmoid Sinus: A Report of Two Cases

Binesh

Khajehzadeh

Kargar

et al. 2015

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

show abstract

“…It was first described by Poncet and Dor in 1897 as botryomycosis hominis based on the assumption that it arose secondary to a fungal infection [ 6 ]. Because it has since been shown to be neither infectious nor granulomatous, the term pyogenic granuloma is now considered a misnomer [ 2 , 3 ]. Based on its histopathological features, the name LCH was assigned to these tumors by Miller [ 7 ].…”

Section: Discussionmentioning

confidence: 99%

“…Grossly, it appears as a polypoidal mass with an ulcerated surface that is covered with fibrin and blood [ 7 ]. Microscopically, it is further characterized by an association with numerous capillary sized blood vessels featuring edematous and inflamed stroma [ 2 – 4 , 7 ]. LCH can be either pedunculated, meaning that it has a stalk that attaches the mass to its site of origin, or it can be sessile, meaning that the mass is fixed to its base without any peduncles [ 8 ].…”

Section: Discussionmentioning

confidence: 99%

“…Hemangiomas are benign vascular lesions commonly found on the skin and oral mucosa, with the nasal cavity being a rare site of involvement [ 1 , 2 ]. They are classified according to their histopathological features.…”

Section: Introductionmentioning

confidence: 99%

“…Proper investigations, including those that employ imaging techniques such as nasal endoscopy, are essential to differentiate LCHs from other dangerous entities, such as inflammatory or neoplastic lesions [ 1 – 5 ]. Despite the availability of multiple treatment options, surgical excision is the most effective form of management [ 1 , 2 ]. In this case report, we describe a 33-year-old female patient in late pregnancy with a history of recurrent episodes of epistaxis and multiple visits to the emergency department.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Intranasal Lobular Capillary Hemangioma with Multiple Sites of Origin during Pregnancy: A Case Report and Literature Review

Alalula

Arafat

Alhedaithy

et al. 2018

Case Reports in Otolaryngology

View full text Add to dashboard Cite

In the present case report, we describe a 33-year-old pregnant woman in the third trimester with a history of recurrent epistaxis leading to frequent visits to the emergency department. Each episode of epistaxis was managed by anterior nasal packing. During endoscopic examination, a left nasal mass was seen. She was admitted and managed conservatively until she delivered her baby without complication. After delivery, a CT scan was taken, which showed an enhancing mass in the middle and lower meatus of the nasal cavity with no bony erosions. For symptomatic relief and tissue diagnosis, endoscopic surgical removal was advised. An intraoperative examination revealed a red, smooth, and well-circumscribed mass occupying the left nasal cavity and originating from the medial surface of the inferior turbinate and the inferior surface of the posterior part of the middle turbinate. A complete en bloc resection of the mass was performed endoscopically. The mass was sent for histologic analysis, which confirmed the diagnosis of lobular capillary hemangioma. Eventually, upon follow-up at two weeks, one month, three months, and six months postsurgery, no evidence of recurrence was detected.

show abstract

Intralesional Bevacizumab for the Treatment of Recurrent Sinonasal Hemangioma

Kinzinger

Strong

Bernard

et al. 2018

Ann Otol Rhinol Laryngol

View full text Add to dashboard Cite

Introduction: Sinonasal hemangioma is a rare benign tumor of vascular endothelial cells. The pathogenesis is closely linked to abnormalities in the vascular endothelial growth factor signaling pathway. Multiple treatment modalities are available, though wide local excision remains the preferred treatment. Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody, has known efficacy against hemangiomas, though there are no cases of sinonasal hemangiomas managed with bevacizumab. Methods: Case report. Results: The authors review the case of a 67-year-old man with a left-sided nasal hemangioma originating from the nasal septum. He presented with progressive left nasal obstruction and recurrent epistaxis. At the time of his presentation, the lesion had recurred after 1 excision/polypectomy at an outside institution. He then underwent revision surgery via wide local excision and septoplasty. After tumor recurrence following the revision surgery, the hemangioma was noted to recur on 1 year postoperative surveillance nasal endoscopy. In-office intralesional injection of 50 mg bevacizumab was then performed under endoscopic visualization. No improvement in the tumor size was noted at 2 months after injection, with the tumor measuring 1.5 cm. At the 10-month surveillance clinical visit following injection, the tumor had dramatically involuted to 3 mm in greatest dimension. The patient reported complete resolution of his primary symptoms of epistaxis and nasal obstruction. Conclusions: This report demonstrates the first reported successful treatment of a sinonasal hemangioma with intralesional bevacizumab. Intralesional bevacizumab confers an additional option for adjuvant treatment of sinonasal hemangiomas. Further evaluation of intralesional bevacizumab in the treatment of these tumors is warranted.

show abstract

Lobular capillary hemangioma of the nasal septum – A case report

Cited by 7 publications

References 6 publications

Lobular Capillary Hemangioma of the Ethmoid Sinus: A Report of Two Cases

Lobular Capillary Hemangioma of the Ethmoid Sinus: A Report of Two Cases

Intranasal Lobular Capillary Hemangioma with Multiple Sites of Origin during Pregnancy: A Case Report and Literature Review

Intralesional Bevacizumab for the Treatment of Recurrent Sinonasal Hemangioma

Contact Info

Product

Resources

About